a retrospective study on persistent pain after childbirth in the netherlands

a retrospective study on persistent pain after childbirth in the netherlands

;Bijl RC;Freeman LM;Weijenborg PTM;Middeldorp JM;Dahan A;van Dorp ELA
waste management (new york, ny) 2016 Vol. 2016 pp. 1-8
163
rc2016journala

Abstract

Rianne C Bijl,1,2 Liv M Freeman,2 Philomeen TM Weijenborg,3 Johanna M Middeldorp,2 Albert Dahan,1 Eveline LA van Dorp1 1Department of Anesthesiology, 2Department of Obstetrics, 3Department of Gynecology, Leiden University Medical Center, Leiden, The NetherlandsAbstract: Reported prevalence rates of persistent postpartum pain (PPP) range from less than 1% to almost 20%. The aim of this study was to examine the prevalence of PPP in a Dutch cohort and to evaluate a possible causal role for specific risk factors on the development of chronic pain after childbirth. A questionnaire was sent to 960 postpartum women approximately 2 years after delivery. Primary outcome was pain that arose from childbirth at follow-up, and secondary outcomes included quality of life (QoL) and Hospital Anxiety and Depression Scale scores. Tested risk factors included mode of labor analgesia, history of negative effect, history of chronic pain, delivery route, parity, and ethnicity. A total of 495 (51.6%) women participated. At a mean time of 2.3 postpartum years, 7.3% of women reported any pain and 6.1% reported significant pain related to the delivery. Compared to spontaneous delivery, cesarean delivery provided protection against persistent pain (odds ratio, 0.12; 95% CI, 0.01–0.63, P<0.05). None of the other risk factors, including remifentanil use for labor pain, were of influence on the prevalence of persistent pain. Women with PPP experienced greater negative effects and had lower QoL scores compared to women without pain. In this cohort of Dutch patients, PPP is a serious problem with a great impact on the physical and mental health of women. Keywords: chronic pain after childbirth, chronic pain, partus, labor analgesia, remifentanil, epidural analgesia, risk factors

Citation

ID: 202570
Ref Key: rc2016journala
Use this key to autocite in SciMatic or Thesis Manager

References

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
202570
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet

Saymatik Web3.0 Wallet